First Time Loading...

Theravance Biopharma Inc
NASDAQ:TBPH

Watchlist Manager
Theravance Biopharma Inc Logo
Theravance Biopharma Inc
NASDAQ:TBPH
Watchlist
Price: 9.12 USD -0.22% Market Closed
Updated: Apr 27, 2024

Theravance Biopharma Inc
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Theravance Biopharma Inc
Operating Income Peer Comparison

Comparables:

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Theravance Biopharma Inc
NASDAQ:TBPH
Operating Income
-$53.3m
CAGR 3-Years
44%
CAGR 5-Years
26%
CAGR 10-Years
10%

See Also

What is Theravance Biopharma Inc's Operating Income?
Operating Income
-53.3m USD

Based on the financial report for Dec 31, 2023, Theravance Biopharma Inc's Operating Income amounts to -53.3m USD.

What is Theravance Biopharma Inc's Operating Income growth rate?
Operating Income CAGR 10Y
10%

Over the last year, the Operating Income growth was 33%. The average annual Operating Income growth rates for Theravance Biopharma Inc have been 44% over the past three years , 26% over the past five years , and 10% over the past ten years .